{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:21:18Z","timestamp":1780413678682,"version":"3.54.1"},"reference-count":26,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2025.2466365","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:50:53Z","timestamp":1741837853000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Number needed to treat (NNT) with pembrolizumab as an adjuvant therapy in resected patients with high-risk stage II (IIB and IIC) melanoma and its application to cost of preventing an event (COPE) in Mexico"],"prefix":"10.1080","volume":"28","author":[{"given":"Victoria","family":"Wurcel","sequence":"first","affiliation":[{"name":"MSD Argentina","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Rojas Rojas","sequence":"additional","affiliation":[{"name":"MSD Colombia","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Urrego-Reyes","sequence":"additional","affiliation":[{"name":"MSD Colombia","place":["Bogot\u00e1, Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Medrano Rivera","sequence":"additional","affiliation":[{"name":"MSD Mexico","place":["Ciudad de Mexico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Acevedo","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Caparros","sequence":"additional","affiliation":[{"name":"MSD Argentina","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Krepler","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Fukunaga-Kalabis","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine D.","family":"Younan","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Alexander","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hughes","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgie","family":"Weston","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.926242"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02484-3"},{"key":"e_1_3_6_4_1","unstructured":"Globocan. Mexico; 2023. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/484-mexico-fact-sheets.pdf"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v11i2.2842"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02525-x"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00562-1"},{"key":"e_1_3_6_9_1","unstructured":"Merck MSD. Keytruda (MK-3475) HTA report - protocol 716: Adjuvant therapy in resected high-risk stage II melanoma - database cut-off Jan 04 2023; 2023."},{"key":"e_1_3_6_10_1","unstructured":"ClinicalTrials.gov. Safety and efficacy of pembrolizumab compared to placebo in resected high-risk stage II melanoma (MK-3475-716\/\u200bKEYNOTE-716). 2024. https:\/\/clinicaltrials.gov\/study\/NCT03553836"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(02)00432-8"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2004.03.025"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cacc.2005.08.003"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.e18899"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1993864"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-23-839"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcskn.2024.100021"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223301"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00559-9"},{"key":"e_1_3_6_20_1","unstructured":"National Cancer Institute. 2024. TNM staging system. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/tnm-staging-system"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1017\/s0022172400014443"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.797"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/ebm.12.4.101"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198806303182605"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0875-8"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.12.022"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12142"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2466365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:49:25Z","timestamp":1766400565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2466365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2466365"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2466365","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}